Elizabeth Hurlburt - Sep 9, 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Operating Officer
Signature
/s/ Elizabeth Hurlburt
Stock symbol
CRMD
Transactions as of
Sep 9, 2025
Transactions value $
-$633,522
Form type
4
Date filed
9/11/2025, 09:45 PM
Previous filing
Sep 8, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hurlburt Elizabeth Chief Operating Officer C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Elizabeth Hurlburt 2025-09-11 0001735256

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $18.7K +12.9K +7.27% $1.45 190K Sep 9, 2025 Direct
transaction CRMD Common Stock Sale -$174K -12.9K -6.78% $13.51 177K Sep 9, 2025 Direct F1
transaction CRMD Common Stock Options Exercise $59.6K +41.1K +23.23% $1.45 218K Sep 11, 2025 Direct
transaction CRMD Common Stock Sale -$538K -41.1K -18.85% $13.08 177K Sep 11, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -12.9K -23.85% $0.00 41.1K Sep 9, 2025 Common Stock 12.9K $1.45 Direct F3
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -41.1K -100% $0.00 0 Sep 11, 2025 Common Stock 41.1K $1.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $13.50 to $13.61. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 This transaction was executed in multiple trades at prices ranging from $12.98 to $13.17. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones.